IP Library Assignment 020940/0901
Patent Assignment
Reel/Frame 020940/0901

Merger

Recorded: 2008-05-07 Pages: 5
Assignor
REXAHN CORPORATION
Executed: 2005-09-29
Assignee
REXAHN PHARMACEUTICALS, INC.
9620 MEDICAL CENTER DRIVE, SUITE 100, ROCKVILLE, MARYLAND, 20850
Covered Property (1)
Nucleoside Derivatives and Therapeutic Use Thereof
Patent: 7,405,214 →
Application: 11/095,686 →
Publication: US 2005/0222185
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 1, 2005
From: LEE, SANG K.
To: REXAHN CORPORATION
Reel/Frame 016445/0956 →
Change of Name Nov 4, 2021
From: REXAHN PHARMACEUTICALS, INC.
To: OCUPHIRE PHARMA, INC.
Reel/Frame 058032/0161 →